Olfactory neuroblastoma with rhabdomyoblasts
Indian Journal of Pathology and Microbiology · 2023
DOI: 10.4103/ijpm.ijpm_209_21 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Indian Journal of Pathology and Microbiology, 2023. Verfasst von Yanling Jin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China. Hauptthemen laut MEDLINE: Esthesioneuroblastoma, Olfactory, Nose Neoplasms. Die Arbeit nennt 7 Literaturangaben.
Abstract (Originalsprache)
Herein we present a case of a 62-year-old male patient who was admitted with the chief complaints of nasal obstruction. The histopathological and immunohistochemical evaluation led to a diagnosis of olfactory neuroblastoma with rhabdomyoblasts. A review of the literature revealed that this is only the fourth case of olfactory neuroblastoma with rhabdomyoblasts. Thus, investigation of more cases and longer follow-up is necessary to understand the disease and identify the best treatment to improve prognosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.
- Department of Radiology, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.
Zitieren
APA
Jin, Y., Zhang, L., Qi, W., Zhou, Y., & Kong, J. (2023). Olfactory neuroblastoma with rhabdomyoblasts. Indian Journal of Pathology and Microbiology. https://doi.org/10.4103/ijpm.ijpm_209_21
Vancouver
Jin Y, Zhang L, Qi W, Zhou Y, Kong J. Olfactory neuroblastoma with rhabdomyoblasts. Indian Journal of Pathology and Microbiology. 2023. doi:10.4103/ijpm.ijpm_209_21
BibTeX
@article{Jin2023,
author = {Jin, Yanling and Zhang, Lizhi and Qi, Wenjing and Zhou, Yujing and Kong, Jienan},
title = {Olfactory neuroblastoma with rhabdomyoblasts},
journal = {Indian Journal of Pathology and Microbiology},
year = {2023},
doi = {10.4103/ijpm.ijpm_209_21}
}
EUVIMED